Literature DB >> 26196940

The broad spectrum 2-oxoglutarate oxygenase inhibitor N-oxalylglycine is present in rhubarb and spinach leaves.

Khalid Al-Qahtani1, Bushra Jabeen2, Rok Sekirnik3, Naheed Riaz4, Timothy D W Claridge3, Christopher J Schofield3, James S O McCullagh5.   

Abstract

2-Oxoglutarate (2OG) and ferrous iron dependent oxygenases are involved in many biological processes in organisms ranging from humans (where some are therapeutic targets) to plants. These enzymes are of significant biomedicinal interest because of their roles in hypoxic signaling and epigenetic regulation. Synthetic N-oxalylglycine (NOG) has been identified as a broad-spectrum 2OG oxygenase inhibitor and is currently widely used in studies on the hypoxic response and chromatin modifications in animals. We report the identification of NOG as a natural product present in Rheum rhabarbarum (rhubarb) and Spinach oleracea (spinach) leaves; NOG was not observed in Escherchia coli or human embryonic kidney cells (HEK 293T). The finding presents the possibility that NOG plays a natural role in regulating gene expression by inhibiting 2OG dependent oxygenases. This has significance because tricarboxylic acid cycle (TCA) intermediate inhibition of 2OG dependent oxygenases has attracted major interest in cancer research.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amino acid; Inhibitor; N-oxalylglycine; Natural product; Oxygenases; Rheum rhabarbarum (rhubarb); Spinach oleracea (spinach)

Mesh:

Substances:

Year:  2015        PMID: 26196940     DOI: 10.1016/j.phytochem.2015.06.028

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  8 in total

1.  In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells.

Authors:  Yu-Te Liu; Chao-Hsiang Hsiao; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  BMC Complement Altern Med       Date:  2019-08-13       Impact factor: 3.659

2.  Targeting MHC Regulation Using Polycyclic Polyprenylated Acylphloroglucinols Isolated from Garcinia bancana.

Authors:  Chloé Coste; Nathalie Gérard; Chau Phi Dinh; Antoine Bruguière; Caroline Rouger; Sow Tein Leong; Khalijah Awang; Pascal Richomme; Séverine Derbré; Béatrice Charreau
Journal:  Biomolecules       Date:  2020-09-02

3.  Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.

Authors:  Lennart Brewitz; Anthony Tumber; Xiaojin Zhang; Christopher J Schofield
Journal:  Bioorg Med Chem       Date:  2020-08-06       Impact factor: 3.641

4.  Traditional Chinese medicine formula T33 inhibits the proliferation of human colorectal cancer cells by inducing autophagy.

Authors:  Yu-Te Liu; Bor-Show Tzang; JiaLe Yow; Yi-Hsuan Chiang; Chih-Yang Huang; Tsai-Ching Hsu
Journal:  Environ Toxicol       Date:  2022-01-07       Impact factor: 4.109

5.  Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase.

Authors:  Lennart Brewitz; Yu Nakashima; Christopher J Schofield
Journal:  Chem Sci       Date:  2020-12-07       Impact factor: 9.825

6.  Fluorinated derivatives of pyridine-2,4-dicarboxylate are potent inhibitors of human 2-oxoglutarate dependent oxygenases.

Authors:  Lennart Brewitz; Yu Nakashima; Anthony Tumber; Eidarus Salah; Christopher J Schofield
Journal:  J Fluor Chem       Date:  2021-07       Impact factor: 2.050

Review 7.  Spectroscopic and in vitro Investigations of Fe2+ /α-Ketoglutarate-Dependent Enzymes Involved in Nucleic Acid Repair and Modification.

Authors:  David Schmidl; Niko S W Lindlar Né Jonasson; Annika Menke; Sabine Schneider; Lena J Daumann
Journal:  Chembiochem       Date:  2022-02-15       Impact factor: 3.461

8.  Synthesis of Novel Pyridine-Carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase.

Authors:  Lennart Brewitz; Anthony Tumber; Armin Thalhammer; Eidarus Salah; Kirsten E Christensen; Christopher J Schofield
Journal:  ChemMedChem       Date:  2020-05-26       Impact factor: 3.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.